P

Inventor

SALL DANIEL JON

US46 patents
⚠️ This page may combine multiple inventors who share the name “SALL DANIEL JON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LILLY CO ELI

43 patents
US6177440B1Jan 23, 2001

Substituted tricyclics

LILLY CO ELI60 citations94
US10654866B2May 19, 2020

Selective estrogen receptor degraders

LILLY CO ELI15 citations93
US6872743B2Mar 29, 2005

sPLA2 inhibitors

LILLY CO ELI21 citations92
US6825220B2Nov 30, 2004

3-Substituted oxindole β 3 agonists

LILLY CO ELI18 citations91
US6730792B2May 4, 2004

β3 adrenergic agonists

LILLY CO ELI21 citations90
US6713645B1Mar 30, 2004

Substituted tricyclics

LILLY CO ELI21 citations90
US6448284B1Sep 10, 2002

Substituted tricyclics

LILLY CO ELI17 citations83
US11117902B2Sep 14, 2021

Selective estrogen receptor degraders

LILLY CO ELI6 citations82
US6025382AFeb 15, 2000

Antithrombotic diamines

LILLY CO ELI15 citations80
US6265416B1Jul 24, 2001

Antithrombotic agents

LILLY CO ELI6 citations73
US7087635B2Aug 8, 2006

3-substituted oxindole β3 agonists

LILLY CO ELI10 citations72
US6911463B2Jun 28, 2005

3-substituted oxindole β-3 agonists

LILLY CO ELI11 citations72
US11634426B2Apr 25, 2023

Selective estrogen receptor degraders

LILLY CO ELI3 citations71
US10759786B2Sep 1, 2020

1-tetrahydropyranylcarbonyl-2,3-dihydro-1H-indole compounds for treating cancer

LILLY CO ELI3 citations70
US9872853B2Jan 23, 2018

2,3-dihydro-1H-indole compounds

LILLY CO ELI4 citations70
US6916840B2Jul 12, 2005

Spla2 inhibitors

LILLY CO ELI2 citations63
US12128040B2Oct 29, 2024

Selective estrogen receptor degraders

LILLY CO ELI0 citations62
US7160909B2Jan 9, 2007

Cyclopenta[b]indole derivatives as sPLA2 inhibitors

LILLY CO ELI5 citations62
US7109231B2Sep 19, 2006

Cyclohept[b]indole derivatives

LILLY CO ELI6 citations62
US7071208B2Jul 4, 2006

β3 Adrenergic agonists

LILLY CO ELI4 citations62
US6974831B2Dec 13, 2005

sPLA2 inhibitors

LILLY CO ELI2 citations62
US6930123B2Aug 16, 2005

sPLA2 inhibitors

LILLY CO ELI2 citations62
US11993608B2May 28, 2024

Selective estrogen receptor degraders

LILLY CO ELI0 citations61
US7122680B2Oct 17, 2006

3-Substituted oxindole β3 agonsists

LILLY CO ELI3 citations61
US6274578B1Aug 14, 2001

sPLA2 inhibitor ester

LILLY CO ELI5 citations61
US6251921B1Jun 26, 2001

Antithrombotic diamines

LILLY CO ELI2 citations61
US6992100B2Jan 31, 2006

sPLA2 inhibitors

LILLY CO ELI3 citations60
US6140327AOct 31, 2000

Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor

LILLY CO ELI4 citations59
US7297706B2Nov 20, 2007

Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders

LILLY CO ELI0 citations52
US7265121B2Sep 4, 2007

Chemical compounds

LILLY CO ELI0 citations52
US7265127B2Sep 4, 2007

β3 adrenergic agonists

LILLY CO ELI0 citations52
US7253181B2Aug 7, 2007

β3 adrenergic agonists

LILLY CO ELI0 citations52
US7241772B2Jul 10, 2007

β3 adrenergic agonists

LILLY CO ELI0 citations52
US7078415B2Jul 18, 2006

Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders

LILLY CO ELI0 citations52
US10344018B2Jul 9, 2019

Pyrazolylaminobenzimidazole derivatives as JAK inhibitors

LILLY CO ELI0 citations51
US10323019B2Jun 18, 2019

Pyrazolylaminobenzimidazole derivatives as JAK inhibitors

LILLY CO ELI0 citations51
US6359136B1Mar 19, 2002

Antithrombotic agents

LILLY CO ELI0 citations50
US6620837B1Sep 16, 2003

Antithrombotic agents

LILLY CO ELI1 citations46
US7205407B2Apr 17, 2007

3-Substituted oxindole β3 agonists

LILLY CO ELI0 citations41
US7115609B2Oct 3, 2006

Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases

LILLY CO ELI0 citations41
US7294627B2Nov 13, 2007

Chemical compounds

LILLY CO ELI0 citations40
US7208505B2Apr 24, 2007

β3 adrenergic agonists

LILLY CO ELI0 citations39
US6133262AOct 17, 2000

Antithrombotic agents

LILLY CO ELI0 citations37

BASTIAN JOLIE ANNE

3 patents